RSV vaccine

First FDA-Approved RSV Vaccines Prevent Respiratory Infections That Pose Serious Hazards to Older Adults

The virus leads to approximately 60,000-120,000 hospitalizations and 6,000-10,000 deaths yearly in people over 65 in the U.S. It also threatens young children and pediatric vaccine approvals are expected soon.